Clavis initiates Elacyt Phase II haematology study
The Phase II part commences after the completion of Phase I, which demonstrated a good safety profile, as well as clinical activity. The Phase II part will evaluate
BeOne Medicines is set to invest $300m in expanding its manufacturing and research operations at the Princeton West Innovation Campus in Hopewell, New Jersey, US.